
Imiro350 mg/ml
Popular Pharmaceuticals Ltd.
Iohexol is a non-ionic, low-osmolar iodinated contrast medium used to enhance visualization of internal structures during radiographic (X-ray/CT) imaging.
Iohexol is a non-ionic, low-osmolar iodinated contrast medium used to enhance visualization of internal structures during radiographic (X-ray/CT) imaging. It is an FDA-approved contrast agent with established uses across several imaging routes:
Iohexol is administered only by, or under the direct supervision of, a qualified physician or radiologist in a healthcare facility; it is not a self-administered outpatient medicine.
Dosage and concentration of Iohexol depend on the imaging procedure, the patient's age, body weight, and renal function, and must be determined by the supervising physician/radiologist. Representative ranges from prescribing information are summarized below; local product labeling should always be followed.
| Indication | Typical adult dose/concentration | Pediatric dose |
|---|---|---|
| Intravenous contrast CT (head/body) | Approx. 300-350 mgI/mL; volume individualized by body weight and study (commonly 50-150 mL) | Weight-based dosing per protocol; lower concentrations used in infants/young children |
| Excretory urography | Approx. 140-350 mgI/mL depending on patient size | Weight-based dosing; used with caution in neonates |
| Lumbar myelography | Approx. 180-240 mgI/mL, small volumes (up to ~17 mL) instilled intrathecally | Not established for routine pediatric myelography except by specialist protocol |
| Cardiac/coronary angiography | Approx. 300-350 mgI/mL, volume per procedure | Specialist pediatric cardiology protocols only |
| Arthrography | Small volume (e.g., 5-15 mL) of lower concentration instilled into the joint | Safety and efficacy not established |
Iohexol must be administered by, or under the supervision of, a physician trained in the procedure and with resuscitation equipment and trained personnel immediately available, because of the risk of serious hypersensitivity reactions.
Adverse effects of Iohexol vary by route of administration.
Patients should seek immediate medical attention for difficulty breathing, swelling of the face/throat, severe rash, or chest pain after Iohexol administration.
Iohexol is contraindicated in patients with a known hypersensitivity to Iohexol or to other iodinated contrast agents.
In addition, when Iohexol is used specifically for hysterosalpingography, it is contraindicated in the following situations: known or suspected pregnancy, during menstruation or when menstruation is imminent, within 6 months after termination of a pregnancy, within 30 days after conization or curettage, and when signs of active infection are present anywhere in the genital tract.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.